Global Oncology Based Preclinical CRO Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Oncology Based Preclinical CRO market size is predicted to grow from US$ 469 million in 2025 to US$ 970 million in 2031; it is expected to grow at a CAGR of 12.9% from 2025 to 2031.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The industry's leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
LPI (LP Information)' newest research report, the “Oncology Based Preclinical CRO Industry Forecast” looks at past sales and reviews total world Oncology Based Preclinical CRO sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Based Preclinical CRO sales for 2025 through 2031. With Oncology Based Preclinical CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Based Preclinical CRO industry.
This Insight Report provides a comprehensive analysis of the global Oncology Based Preclinical CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncology Based Preclinical CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Based Preclinical CRO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Based Preclinical CRO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Based Preclinical CRO.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Based Preclinical CRO market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Oncology Based Preclinical CRO market size is predicted to grow from US$ 469 million in 2025 to US$ 970 million in 2031; it is expected to grow at a CAGR of 12.9% from 2025 to 2031.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The industry's leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
LPI (LP Information)' newest research report, the “Oncology Based Preclinical CRO Industry Forecast” looks at past sales and reviews total world Oncology Based Preclinical CRO sales in 2024, providing a comprehensive analysis by region and market sector of projected Oncology Based Preclinical CRO sales for 2025 through 2031. With Oncology Based Preclinical CRO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Based Preclinical CRO industry.
This Insight Report provides a comprehensive analysis of the global Oncology Based Preclinical CRO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncology Based Preclinical CRO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Based Preclinical CRO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Based Preclinical CRO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Based Preclinical CRO.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Based Preclinical CRO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Blood Cancer
- Solid Tumors
- Others
- In Vitro
- In Vivo
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Crown Bioscience
- Charles River
- ICON
- Eurofins Scientific
- Taconic Biosciences
- Covance
- EVOTEC
- The Jackson Laboratory
- MI Bioresearch
- Champion Oncology
- Wuxi AppTec.
- Xentech
- Living Tumor Laboratory
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Based Preclinical CRO Market Size (2020-2031)
2.1.2 Oncology Based Preclinical CRO Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oncology Based Preclinical CRO by Country/Region (2020, 2024 & 2031)
2.2 Oncology Based Preclinical CRO Segment by Type
2.2.1 Blood Cancer
2.2.2 Solid Tumors
2.2.3 Others
2.3 Oncology Based Preclinical CRO Market Size by Type
2.3.1 Oncology Based Preclinical CRO Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oncology Based Preclinical CRO Market Size Market Share by Type (2020-2025)
2.4 Oncology Based Preclinical CRO Segment by Application
2.4.1 In Vitro
2.4.2 In Vivo
2.5 Oncology Based Preclinical CRO Market Size by Application
2.5.1 Oncology Based Preclinical CRO Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
3 ONCOLOGY BASED PRECLINICAL CRO MARKET SIZE BY PLAYER
3.1 Oncology Based Preclinical CRO Market Size Market Share by Player
3.1.1 Global Oncology Based Preclinical CRO Revenue by Player (2020-2025)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Player (2020-2025)
3.2 Global Oncology Based Preclinical CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY BASED PRECLINICAL CRO BY REGION
4.1 Oncology Based Preclinical CRO Market Size by Region (2020-2025)
4.2 Global Oncology Based Preclinical CRO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Based Preclinical CRO Market Size Growth (2020-2025)
4.4 APAC Oncology Based Preclinical CRO Market Size Growth (2020-2025)
4.5 Europe Oncology Based Preclinical CRO Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncology Based Preclinical CRO Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oncology Based Preclinical CRO Market Size by Country (2020-2025)
5.2 Americas Oncology Based Preclinical CRO Market Size by Type (2020-2025)
5.3 Americas Oncology Based Preclinical CRO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Based Preclinical CRO Market Size by Region (2020-2025)
6.2 APAC Oncology Based Preclinical CRO Market Size by Type (2020-2025)
6.3 APAC Oncology Based Preclinical CRO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Based Preclinical CRO Market Size by Country (2020-2025)
7.2 Europe Oncology Based Preclinical CRO Market Size by Type (2020-2025)
7.3 Europe Oncology Based Preclinical CRO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Based Preclinical CRO by Region (2020-2025)
8.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY BASED PRECLINICAL CRO MARKET FORECAST
10.1 Global Oncology Based Preclinical CRO Forecast by Region (2026-2031)
10.1.1 Global Oncology Based Preclinical CRO Forecast by Region (2026-2031)
10.1.2 Americas Oncology Based Preclinical CRO Forecast
10.1.3 APAC Oncology Based Preclinical CRO Forecast
10.1.4 Europe Oncology Based Preclinical CRO Forecast
10.1.5 Middle East & Africa Oncology Based Preclinical CRO Forecast
10.2 Americas Oncology Based Preclinical CRO Forecast by Country (2026-2031)
10.2.1 United States Market Oncology Based Preclinical CRO Forecast
10.2.2 Canada Market Oncology Based Preclinical CRO Forecast
10.2.3 Mexico Market Oncology Based Preclinical CRO Forecast
10.2.4 Brazil Market Oncology Based Preclinical CRO Forecast
10.3 APAC Oncology Based Preclinical CRO Forecast by Region (2026-2031)
10.3.1 China Oncology Based Preclinical CRO Market Forecast
10.3.2 Japan Market Oncology Based Preclinical CRO Forecast
10.3.3 Korea Market Oncology Based Preclinical CRO Forecast
10.3.4 Southeast Asia Market Oncology Based Preclinical CRO Forecast
10.3.5 India Market Oncology Based Preclinical CRO Forecast
10.3.6 Australia Market Oncology Based Preclinical CRO Forecast
10.4 Europe Oncology Based Preclinical CRO Forecast by Country (2026-2031)
10.4.1 Germany Market Oncology Based Preclinical CRO Forecast
10.4.2 France Market Oncology Based Preclinical CRO Forecast
10.4.3 UK Market Oncology Based Preclinical CRO Forecast
10.4.4 Italy Market Oncology Based Preclinical CRO Forecast
10.4.5 Russia Market Oncology Based Preclinical CRO Forecast
10.5 Middle East & Africa Oncology Based Preclinical CRO Forecast by Region (2026-2031)
10.5.1 Egypt Market Oncology Based Preclinical CRO Forecast
10.5.2 South Africa Market Oncology Based Preclinical CRO Forecast
10.5.3 Israel Market Oncology Based Preclinical CRO Forecast
10.5.4 Turkey Market Oncology Based Preclinical CRO Forecast
10.6 Global Oncology Based Preclinical CRO Forecast by Type (2026-2031)
10.7 Global Oncology Based Preclinical CRO Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oncology Based Preclinical CRO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Information
11.1.2 Crown Bioscience Oncology Based Preclinical CRO Product Offered
11.1.3 Crown Bioscience Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Crown Bioscience Main Business Overview
11.1.5 Crown Bioscience Latest Developments
11.2 Charles River
11.2.1 Charles River Company Information
11.2.2 Charles River Oncology Based Preclinical CRO Product Offered
11.2.3 Charles River Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Charles River Main Business Overview
11.2.5 Charles River Latest Developments
11.3 ICON
11.3.1 ICON Company Information
11.3.2 ICON Oncology Based Preclinical CRO Product Offered
11.3.3 ICON Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 ICON Main Business Overview
11.3.5 ICON Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Oncology Based Preclinical CRO Product Offered
11.4.3 Eurofins Scientific Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Information
11.5.2 Taconic Biosciences Oncology Based Preclinical CRO Product Offered
11.5.3 Taconic Biosciences Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Taconic Biosciences Main Business Overview
11.5.5 Taconic Biosciences Latest Developments
11.6 Covance
11.6.1 Covance Company Information
11.6.2 Covance Oncology Based Preclinical CRO Product Offered
11.6.3 Covance Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Covance Main Business Overview
11.6.5 Covance Latest Developments
11.7 EVOTEC
11.7.1 EVOTEC Company Information
11.7.2 EVOTEC Oncology Based Preclinical CRO Product Offered
11.7.3 EVOTEC Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 EVOTEC Main Business Overview
11.7.5 EVOTEC Latest Developments
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Information
11.8.2 The Jackson Laboratory Oncology Based Preclinical CRO Product Offered
11.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 The Jackson Laboratory Main Business Overview
11.8.5 The Jackson Laboratory Latest Developments
11.9 MI Bioresearch
11.9.1 MI Bioresearch Company Information
11.9.2 MI Bioresearch Oncology Based Preclinical CRO Product Offered
11.9.3 MI Bioresearch Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 MI Bioresearch Main Business Overview
11.9.5 MI Bioresearch Latest Developments
11.10 Champion Oncology
11.10.1 Champion Oncology Company Information
11.10.2 Champion Oncology Oncology Based Preclinical CRO Product Offered
11.10.3 Champion Oncology Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Champion Oncology Main Business Overview
11.10.5 Champion Oncology Latest Developments
11.11 Wuxi AppTec.
11.11.1 Wuxi AppTec. Company Information
11.11.2 Wuxi AppTec. Oncology Based Preclinical CRO Product Offered
11.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Wuxi AppTec. Main Business Overview
11.11.5 Wuxi AppTec. Latest Developments
11.12 Xentech
11.12.1 Xentech Company Information
11.12.2 Xentech Oncology Based Preclinical CRO Product Offered
11.12.3 Xentech Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Xentech Main Business Overview
11.12.5 Xentech Latest Developments
11.13 Living Tumor Laboratory
11.13.1 Living Tumor Laboratory Company Information
11.13.2 Living Tumor Laboratory Oncology Based Preclinical CRO Product Offered
11.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Living Tumor Laboratory Main Business Overview
11.13.5 Living Tumor Laboratory Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oncology Based Preclinical CRO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncology Based Preclinical CRO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Blood Cancer
Table 4. Major Players of SolidTumors
Table 5. Major Players of Others
Table 6. Oncology Based Preclinical CRO Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 8. Global Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Table 9. Oncology Based Preclinical CRO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Table 12. Global Oncology Based Preclinical CRO Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Oncology Based Preclinical CRO Revenue Market Share by Player (2020-2025)
Table 14. Oncology Based Preclinical CRO Key Players Head office and Products Offered
Table 15. Oncology Based Preclinical CRO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oncology Based Preclinical CRO Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Oncology Based Preclinical CRO Market Size Market Share by Region (2020-2025)
Table 20. Global Oncology Based Preclinical CRO Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Oncology Based Preclinical CRO Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Oncology Based Preclinical CRO Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Oncology Based Preclinical CRO Market Size Market Share by Country (2020-2025)
Table 24. Americas Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Table 26. Americas Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Table 28. APAC Oncology Based Preclinical CRO Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Oncology Based Preclinical CRO Market Size Market Share by Region (2020-2025)
Table 30. APAC Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Oncology Based Preclinical CRO Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Oncology Based Preclinical CRO Market Size Market Share by Country (2020-2025)
Table 34. Europe Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Oncology Based Preclinical CRO Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Oncology Based Preclinical CRO
Table 40. Key Market Challenges & Risks of Oncology Based Preclinical CRO
Table 41. Key IndustryTrends of Oncology Based Preclinical CRO
Table 42. Global Oncology Based Preclinical CRO Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Oncology Based Preclinical CRO Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Oncology Based Preclinical CRO Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Oncology Based Preclinical CRO Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Crown Bioscience Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 47. Crown Bioscience Oncology Based Preclinical CRO Product Offered
Table 48. Crown Bioscience Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Crown Bioscience Main Business
Table 50. Crown Bioscience Latest Developments
Table 51. Charles River Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 52. Charles River Oncology Based Preclinical CRO Product Offered
Table 53. Charles River Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Charles River Main Business
Table 55. Charles River Latest Developments
Table 56. ICON Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 57. ICON Oncology Based Preclinical CRO Product Offered
Table 58. ICON Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. ICON Main Business
Table 60. ICON Latest Developments
Table 61. Eurofins Scientific Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 62. Eurofins Scientific Oncology Based Preclinical CRO Product Offered
Table 63. Eurofins Scientific Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Eurofins Scientific Main Business
Table 65. Eurofins Scientific Latest Developments
Table 66.Taconic Biosciences Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 67.Taconic Biosciences Oncology Based Preclinical CRO Product Offered
Table 68.Taconic Biosciences Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69.Taconic Biosciences Main Business
Table 70.Taconic Biosciences Latest Developments
Table 71. Covance Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 72. Covance Oncology Based Preclinical CRO Product Offered
Table 73. Covance Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Covance Main Business
Table 75. Covance Latest Developments
Table 76. EVOTEC Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 77. EVOTEC Oncology Based Preclinical CRO Product Offered
Table 78. EVOTEC Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. EVOTEC Main Business
Table 80. EVOTEC Latest Developments
Table 81.The Jackson Laboratory Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 82.The Jackson Laboratory Oncology Based Preclinical CRO Product Offered
Table 83.The Jackson Laboratory Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84.The Jackson Laboratory Main Business
Table 85.The Jackson Laboratory Latest Developments
Table 86. MI Bioresearch Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 87. MI Bioresearch Oncology Based Preclinical CRO Product Offered
Table 88. MI Bioresearch Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. MI Bioresearch Main Business
Table 90. MI Bioresearch Latest Developments
Table 91. Champion Oncology Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 92. Champion Oncology Oncology Based Preclinical CRO Product Offered
Table 93. Champion Oncology Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Champion Oncology Main Business
Table 95. Champion Oncology Latest Developments
Table 96. Wuxi AppTec. Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 97. Wuxi AppTec. Oncology Based Preclinical CRO Product Offered
Table 98. Wuxi AppTec. Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Wuxi AppTec. Main Business
Table 100. Wuxi AppTec. Latest Developments
Table 101. Xentech Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 102. Xentech Oncology Based Preclinical CRO Product Offered
Table 103. Xentech Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Xentech Main Business
Table 105. Xentech Latest Developments
Table 106. LivingTumor Laboratory Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 107. LivingTumor Laboratory Oncology Based Preclinical CRO Product Offered
Table 108. LivingTumor Laboratory Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. LivingTumor Laboratory Main Business
Table 110. LivingTumor Laboratory Latest Developments
LIST OFFIGURES
Figure 1. Oncology Based Preclinical CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Based Preclinical CRO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncology Based Preclinical CRO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncology Based Preclinical CRO Sales Market Share by Country/Region (2024)
Figure 8. Oncology Based Preclinical CRO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncology Based Preclinical CRO Market Size Market Share byType in 2024
Figure 10. Oncology Based Preclinical CRO in In Vitro
Figure 11. Global Oncology Based Preclinical CRO Market: In Vitro (2020-2025) & ($ millions)
Figure 12. Oncology Based Preclinical CRO in In Vivo
Figure 13. Global Oncology Based Preclinical CRO Market: In Vivo (2020-2025) & ($ millions)
Figure 14. Global Oncology Based Preclinical CRO Market Size Market Share by Application in 2024
Figure 15. Global Oncology Based Preclinical CRO Revenue Market Share by Player in 2024
Figure 16. Global Oncology Based Preclinical CRO Market Size Market Share by Region (2020-2025)
Figure 17. Americas Oncology Based Preclinical CRO Market Size 2020-2025 ($ millions)
Figure 18. APAC Oncology Based Preclinical CRO Market Size 2020-2025 ($ millions)
Figure 19. Europe Oncology Based Preclinical CRO Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Oncology Based Preclinical CRO Market Size 2020-2025 ($ millions)
Figure 21. Americas Oncology Based Preclinical CRO Value Market Share by Country in 2024
Figure 22. United States Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Oncology Based Preclinical CRO Market Size Market Share by Region in 2024
Figure 27. APAC Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Figure 28. APAC Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Figure 29. China Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 33. India Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Oncology Based Preclinical CRO Market Size Market Share by Country in 2024
Figure 36. Europe Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Figure 37. Europe Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Figure 38. Germany Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 39.France Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 52. APAC Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 53. Europe Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 55. United States Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 56. Canada Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 57. Mexico Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 58. Brazil Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 59. China Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 60. Japan Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 61. Korea Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 63. India Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 64. Australia Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 65. Germany Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 66.France Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 67. UK Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 68. Italy Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 69. Russia Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 70. Egypt Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 71. South Africa Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 72. Israel Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 73.Turkey Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 74. Global Oncology Based Preclinical CRO Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Oncology Based Preclinical CRO Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Based Preclinical CRO Market Size (2020-2031)
2.1.2 Oncology Based Preclinical CRO Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oncology Based Preclinical CRO by Country/Region (2020, 2024 & 2031)
2.2 Oncology Based Preclinical CRO Segment by Type
2.2.1 Blood Cancer
2.2.2 Solid Tumors
2.2.3 Others
2.3 Oncology Based Preclinical CRO Market Size by Type
2.3.1 Oncology Based Preclinical CRO Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oncology Based Preclinical CRO Market Size Market Share by Type (2020-2025)
2.4 Oncology Based Preclinical CRO Segment by Application
2.4.1 In Vitro
2.4.2 In Vivo
2.5 Oncology Based Preclinical CRO Market Size by Application
2.5.1 Oncology Based Preclinical CRO Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
3 ONCOLOGY BASED PRECLINICAL CRO MARKET SIZE BY PLAYER
3.1 Oncology Based Preclinical CRO Market Size Market Share by Player
3.1.1 Global Oncology Based Preclinical CRO Revenue by Player (2020-2025)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Player (2020-2025)
3.2 Global Oncology Based Preclinical CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY BASED PRECLINICAL CRO BY REGION
4.1 Oncology Based Preclinical CRO Market Size by Region (2020-2025)
4.2 Global Oncology Based Preclinical CRO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oncology Based Preclinical CRO Market Size Growth (2020-2025)
4.4 APAC Oncology Based Preclinical CRO Market Size Growth (2020-2025)
4.5 Europe Oncology Based Preclinical CRO Market Size Growth (2020-2025)
4.6 Middle East & Africa Oncology Based Preclinical CRO Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oncology Based Preclinical CRO Market Size by Country (2020-2025)
5.2 Americas Oncology Based Preclinical CRO Market Size by Type (2020-2025)
5.3 Americas Oncology Based Preclinical CRO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Based Preclinical CRO Market Size by Region (2020-2025)
6.2 APAC Oncology Based Preclinical CRO Market Size by Type (2020-2025)
6.3 APAC Oncology Based Preclinical CRO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Based Preclinical CRO Market Size by Country (2020-2025)
7.2 Europe Oncology Based Preclinical CRO Market Size by Type (2020-2025)
7.3 Europe Oncology Based Preclinical CRO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Based Preclinical CRO by Region (2020-2025)
8.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2020-2025)
8.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY BASED PRECLINICAL CRO MARKET FORECAST
10.1 Global Oncology Based Preclinical CRO Forecast by Region (2026-2031)
10.1.1 Global Oncology Based Preclinical CRO Forecast by Region (2026-2031)
10.1.2 Americas Oncology Based Preclinical CRO Forecast
10.1.3 APAC Oncology Based Preclinical CRO Forecast
10.1.4 Europe Oncology Based Preclinical CRO Forecast
10.1.5 Middle East & Africa Oncology Based Preclinical CRO Forecast
10.2 Americas Oncology Based Preclinical CRO Forecast by Country (2026-2031)
10.2.1 United States Market Oncology Based Preclinical CRO Forecast
10.2.2 Canada Market Oncology Based Preclinical CRO Forecast
10.2.3 Mexico Market Oncology Based Preclinical CRO Forecast
10.2.4 Brazil Market Oncology Based Preclinical CRO Forecast
10.3 APAC Oncology Based Preclinical CRO Forecast by Region (2026-2031)
10.3.1 China Oncology Based Preclinical CRO Market Forecast
10.3.2 Japan Market Oncology Based Preclinical CRO Forecast
10.3.3 Korea Market Oncology Based Preclinical CRO Forecast
10.3.4 Southeast Asia Market Oncology Based Preclinical CRO Forecast
10.3.5 India Market Oncology Based Preclinical CRO Forecast
10.3.6 Australia Market Oncology Based Preclinical CRO Forecast
10.4 Europe Oncology Based Preclinical CRO Forecast by Country (2026-2031)
10.4.1 Germany Market Oncology Based Preclinical CRO Forecast
10.4.2 France Market Oncology Based Preclinical CRO Forecast
10.4.3 UK Market Oncology Based Preclinical CRO Forecast
10.4.4 Italy Market Oncology Based Preclinical CRO Forecast
10.4.5 Russia Market Oncology Based Preclinical CRO Forecast
10.5 Middle East & Africa Oncology Based Preclinical CRO Forecast by Region (2026-2031)
10.5.1 Egypt Market Oncology Based Preclinical CRO Forecast
10.5.2 South Africa Market Oncology Based Preclinical CRO Forecast
10.5.3 Israel Market Oncology Based Preclinical CRO Forecast
10.5.4 Turkey Market Oncology Based Preclinical CRO Forecast
10.6 Global Oncology Based Preclinical CRO Forecast by Type (2026-2031)
10.7 Global Oncology Based Preclinical CRO Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oncology Based Preclinical CRO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Information
11.1.2 Crown Bioscience Oncology Based Preclinical CRO Product Offered
11.1.3 Crown Bioscience Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Crown Bioscience Main Business Overview
11.1.5 Crown Bioscience Latest Developments
11.2 Charles River
11.2.1 Charles River Company Information
11.2.2 Charles River Oncology Based Preclinical CRO Product Offered
11.2.3 Charles River Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Charles River Main Business Overview
11.2.5 Charles River Latest Developments
11.3 ICON
11.3.1 ICON Company Information
11.3.2 ICON Oncology Based Preclinical CRO Product Offered
11.3.3 ICON Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 ICON Main Business Overview
11.3.5 ICON Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Oncology Based Preclinical CRO Product Offered
11.4.3 Eurofins Scientific Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Information
11.5.2 Taconic Biosciences Oncology Based Preclinical CRO Product Offered
11.5.3 Taconic Biosciences Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Taconic Biosciences Main Business Overview
11.5.5 Taconic Biosciences Latest Developments
11.6 Covance
11.6.1 Covance Company Information
11.6.2 Covance Oncology Based Preclinical CRO Product Offered
11.6.3 Covance Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Covance Main Business Overview
11.6.5 Covance Latest Developments
11.7 EVOTEC
11.7.1 EVOTEC Company Information
11.7.2 EVOTEC Oncology Based Preclinical CRO Product Offered
11.7.3 EVOTEC Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 EVOTEC Main Business Overview
11.7.5 EVOTEC Latest Developments
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Information
11.8.2 The Jackson Laboratory Oncology Based Preclinical CRO Product Offered
11.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 The Jackson Laboratory Main Business Overview
11.8.5 The Jackson Laboratory Latest Developments
11.9 MI Bioresearch
11.9.1 MI Bioresearch Company Information
11.9.2 MI Bioresearch Oncology Based Preclinical CRO Product Offered
11.9.3 MI Bioresearch Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 MI Bioresearch Main Business Overview
11.9.5 MI Bioresearch Latest Developments
11.10 Champion Oncology
11.10.1 Champion Oncology Company Information
11.10.2 Champion Oncology Oncology Based Preclinical CRO Product Offered
11.10.3 Champion Oncology Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Champion Oncology Main Business Overview
11.10.5 Champion Oncology Latest Developments
11.11 Wuxi AppTec.
11.11.1 Wuxi AppTec. Company Information
11.11.2 Wuxi AppTec. Oncology Based Preclinical CRO Product Offered
11.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Wuxi AppTec. Main Business Overview
11.11.5 Wuxi AppTec. Latest Developments
11.12 Xentech
11.12.1 Xentech Company Information
11.12.2 Xentech Oncology Based Preclinical CRO Product Offered
11.12.3 Xentech Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Xentech Main Business Overview
11.12.5 Xentech Latest Developments
11.13 Living Tumor Laboratory
11.13.1 Living Tumor Laboratory Company Information
11.13.2 Living Tumor Laboratory Oncology Based Preclinical CRO Product Offered
11.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Living Tumor Laboratory Main Business Overview
11.13.5 Living Tumor Laboratory Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oncology Based Preclinical CRO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oncology Based Preclinical CRO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Blood Cancer
Table 4. Major Players of SolidTumors
Table 5. Major Players of Others
Table 6. Oncology Based Preclinical CRO Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 8. Global Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Table 9. Oncology Based Preclinical CRO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Table 12. Global Oncology Based Preclinical CRO Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Oncology Based Preclinical CRO Revenue Market Share by Player (2020-2025)
Table 14. Oncology Based Preclinical CRO Key Players Head office and Products Offered
Table 15. Oncology Based Preclinical CRO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oncology Based Preclinical CRO Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Oncology Based Preclinical CRO Market Size Market Share by Region (2020-2025)
Table 20. Global Oncology Based Preclinical CRO Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Oncology Based Preclinical CRO Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Oncology Based Preclinical CRO Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Oncology Based Preclinical CRO Market Size Market Share by Country (2020-2025)
Table 24. Americas Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 25. Americas Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Table 26. Americas Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Table 28. APAC Oncology Based Preclinical CRO Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Oncology Based Preclinical CRO Market Size Market Share by Region (2020-2025)
Table 30. APAC Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 31. APAC Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Oncology Based Preclinical CRO Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Oncology Based Preclinical CRO Market Size Market Share by Country (2020-2025)
Table 34. Europe Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 35. Europe Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Oncology Based Preclinical CRO Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oncology Based Preclinical CRO Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Oncology Based Preclinical CRO
Table 40. Key Market Challenges & Risks of Oncology Based Preclinical CRO
Table 41. Key IndustryTrends of Oncology Based Preclinical CRO
Table 42. Global Oncology Based Preclinical CRO Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. Global Oncology Based Preclinical CRO Market Size Market ShareForecast by Region (2026-2031)
Table 44. Global Oncology Based Preclinical CRO Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. Global Oncology Based Preclinical CRO Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Crown Bioscience Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 47. Crown Bioscience Oncology Based Preclinical CRO Product Offered
Table 48. Crown Bioscience Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Crown Bioscience Main Business
Table 50. Crown Bioscience Latest Developments
Table 51. Charles River Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 52. Charles River Oncology Based Preclinical CRO Product Offered
Table 53. Charles River Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Charles River Main Business
Table 55. Charles River Latest Developments
Table 56. ICON Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 57. ICON Oncology Based Preclinical CRO Product Offered
Table 58. ICON Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. ICON Main Business
Table 60. ICON Latest Developments
Table 61. Eurofins Scientific Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 62. Eurofins Scientific Oncology Based Preclinical CRO Product Offered
Table 63. Eurofins Scientific Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Eurofins Scientific Main Business
Table 65. Eurofins Scientific Latest Developments
Table 66.Taconic Biosciences Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 67.Taconic Biosciences Oncology Based Preclinical CRO Product Offered
Table 68.Taconic Biosciences Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69.Taconic Biosciences Main Business
Table 70.Taconic Biosciences Latest Developments
Table 71. Covance Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 72. Covance Oncology Based Preclinical CRO Product Offered
Table 73. Covance Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Covance Main Business
Table 75. Covance Latest Developments
Table 76. EVOTEC Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 77. EVOTEC Oncology Based Preclinical CRO Product Offered
Table 78. EVOTEC Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. EVOTEC Main Business
Table 80. EVOTEC Latest Developments
Table 81.The Jackson Laboratory Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 82.The Jackson Laboratory Oncology Based Preclinical CRO Product Offered
Table 83.The Jackson Laboratory Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84.The Jackson Laboratory Main Business
Table 85.The Jackson Laboratory Latest Developments
Table 86. MI Bioresearch Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 87. MI Bioresearch Oncology Based Preclinical CRO Product Offered
Table 88. MI Bioresearch Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. MI Bioresearch Main Business
Table 90. MI Bioresearch Latest Developments
Table 91. Champion Oncology Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 92. Champion Oncology Oncology Based Preclinical CRO Product Offered
Table 93. Champion Oncology Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Champion Oncology Main Business
Table 95. Champion Oncology Latest Developments
Table 96. Wuxi AppTec. Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 97. Wuxi AppTec. Oncology Based Preclinical CRO Product Offered
Table 98. Wuxi AppTec. Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Wuxi AppTec. Main Business
Table 100. Wuxi AppTec. Latest Developments
Table 101. Xentech Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 102. Xentech Oncology Based Preclinical CRO Product Offered
Table 103. Xentech Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Xentech Main Business
Table 105. Xentech Latest Developments
Table 106. LivingTumor Laboratory Details, CompanyType, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 107. LivingTumor Laboratory Oncology Based Preclinical CRO Product Offered
Table 108. LivingTumor Laboratory Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. LivingTumor Laboratory Main Business
Table 110. LivingTumor Laboratory Latest Developments
LIST OFFIGURES
Figure 1. Oncology Based Preclinical CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Based Preclinical CRO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oncology Based Preclinical CRO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oncology Based Preclinical CRO Sales Market Share by Country/Region (2024)
Figure 8. Oncology Based Preclinical CRO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oncology Based Preclinical CRO Market Size Market Share byType in 2024
Figure 10. Oncology Based Preclinical CRO in In Vitro
Figure 11. Global Oncology Based Preclinical CRO Market: In Vitro (2020-2025) & ($ millions)
Figure 12. Oncology Based Preclinical CRO in In Vivo
Figure 13. Global Oncology Based Preclinical CRO Market: In Vivo (2020-2025) & ($ millions)
Figure 14. Global Oncology Based Preclinical CRO Market Size Market Share by Application in 2024
Figure 15. Global Oncology Based Preclinical CRO Revenue Market Share by Player in 2024
Figure 16. Global Oncology Based Preclinical CRO Market Size Market Share by Region (2020-2025)
Figure 17. Americas Oncology Based Preclinical CRO Market Size 2020-2025 ($ millions)
Figure 18. APAC Oncology Based Preclinical CRO Market Size 2020-2025 ($ millions)
Figure 19. Europe Oncology Based Preclinical CRO Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Oncology Based Preclinical CRO Market Size 2020-2025 ($ millions)
Figure 21. Americas Oncology Based Preclinical CRO Value Market Share by Country in 2024
Figure 22. United States Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Oncology Based Preclinical CRO Market Size Market Share by Region in 2024
Figure 27. APAC Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Figure 28. APAC Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Figure 29. China Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 33. India Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Oncology Based Preclinical CRO Market Size Market Share by Country in 2024
Figure 36. Europe Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Figure 37. Europe Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Figure 38. Germany Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 39.France Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Oncology Based Preclinical CRO Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 52. APAC Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 53. Europe Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 55. United States Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 56. Canada Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 57. Mexico Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 58. Brazil Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 59. China Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 60. Japan Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 61. Korea Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 63. India Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 64. Australia Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 65. Germany Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 66.France Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 67. UK Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 68. Italy Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 69. Russia Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 70. Egypt Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 71. South Africa Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 72. Israel Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 73.Turkey Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
Figure 74. Global Oncology Based Preclinical CRO Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Oncology Based Preclinical CRO Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Oncology Based Preclinical CRO Market Size 2026-2031 ($ millions)
More Publications
Global Respiratory System Stents Market Growth 2024-2030
US$ 3,660.00
March 2024
89 pages
Global Contact Cardiac Mapping System Market Growth 2024-2030
US$ 3,660.00
June 2024
77 pages
Global Radiopharmaceutical Market Growth 2025-2031
US$ 3,660.00
March 2025
110 pages
Global Medical Tapes Market Growth 2025-2031
US$ 3,660.00
December 2024
166 pages
